Avidity Biosciences Total Current Liabilities 2019-2024 | RNA

Avidity Biosciences total current liabilities for the quarter ending September 30, 2024 were $0.091B, a 87.48% increase year-over-year.

  • Avidity Biosciences total current liabilities for 2023 were $0.081B, a 55.43% increase from 2022.
  • Avidity Biosciences total current liabilities for 2022 were $0.052B, a 75.02% increase from 2021.
  • Avidity Biosciences total current liabilities for 2021 were $0.03B, a 103.32% increase from 2020.

Avidity Biosciences Total Current Liabilities 2019-2024 | RNA

  • Avidity Biosciences total current liabilities for 2023 were $0.081B, a 55.43% increase from 2022.
  • Avidity Biosciences total current liabilities for 2022 were $0.052B, a 75.02% increase from 2021.
  • Avidity Biosciences total current liabilities for 2021 were $0.03B, a 103.32% increase from 2020.